Orchard Therapeutics plc (ORTX)
Jan 24, 2024 - ORTX was delisted (reason: acquired by Kyowa Kirin)
0.00 (0.00%)
Last trade price

Orchard Therapeutics Revenue

Orchard Therapeutics had revenue of $21.84M in the twelve months ending September 30, 2023, with 35.21% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $6.30M with 9.09% year-over-year growth. In the year 2022, Orchard Therapeutics had annual revenue of $22.66M with 1,252.54% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
756.82M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 202222.66M20.98M1,252.54%
Dec 31, 20211.68M-920.00K-35.45%
Dec 31, 20202.60M82.00K3.26%
Dec 31, 20192.51M437.00K21.05%
Dec 31, 20182.08M--
Dec 31, 20170--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.